Shields PG - Search Results

1

Serum, plasma and paraffin-embedded tissues as sources of DNA for studying cancer susceptibility genes.

Blömeke B, Bennett WP, Harris CC, Shields PG. Blömeke B, et al. Among authors: shields pg. Carcinogenesis. 1997 Jun;18(6):1271-5. doi: 10.1093/carcin/18.6.1271. Carcinogenesis. 1997. PMID: 9214613

2

Distribution of 7-alkyl-2'-deoxyguanosine adduct levels in human lung.

Blömeke B, Greenblatt MJ, Doan VD, Bowman ED, Murphy SE, Chen CC, Kato S, Shields PG. Blömeke B, et al. Among authors: shields pg. Carcinogenesis. 1996 Apr;17(4):741-8. doi: 10.1093/carcin/17.4.741. Carcinogenesis. 1996. PMID: 8625485

3

p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer.

Przygodzki RM, Bennett WP, Guinee DG Jr, Khan MA, Freedman A, Shields PG, Travis WD, Jett JR, Tazelaar H, Pairolero P, Trastek V, Liotta LA, Harris CC, Caporaso NE. Przygodzki RM, et al. Among authors: shields pg. Pharmacogenetics. 1998 Dec;8(6):503-11. doi: 10.1097/00008571-199812000-00007. Pharmacogenetics. 1998. PMID: 9918134

4

Laboratory methods for the determination of genetic polymorphisms in humans.

Blömeke B, Shields PG. Blömeke B, et al. Among authors: shields pg. IARC Sci Publ. 1999;(148):133-47. IARC Sci Publ. 1999. PMID: 10493255 Review.

5

Polymorphisms in XPD and TP53 and mutation in human lung cancer.

Mechanic LE, Marrogi AJ, Welsh JA, Bowman ED, Khan MA, Enewold L, Zheng YL, Chanock S, Shields PG, Harris CC. Mechanic LE, et al. Among authors: shields pg. Carcinogenesis. 2005 Mar;26(3):597-604. doi: 10.1093/carcin/bgh344. Epub 2004 Nov 25. Carcinogenesis. 2005. PMID: 15564288

6

Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls.

Zheng YL, Loffredo CA, Yu Z, Jones RT, Krasna MJ, Alberg AJ, Yung R, Perlmutter D, Enewold L, Harris CC, Shields PG. Zheng YL, et al. Among authors: shields pg. Carcinogenesis. 2003 Feb;24(2):269-74. doi: 10.1093/carcin/24.2.269. Carcinogenesis. 2003. PMID: 12584177

7

Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer.

Kato S, Shields PG, Caporaso NE, Sugimura H, Trivers GE, Tucker MA, Trump BF, Weston A, Harris CC. Kato S, et al. Among authors: shields pg. Cancer Epidemiol Biomarkers Prev. 1994 Sep;3(6):515-8. Cancer Epidemiol Biomarkers Prev. 1994. PMID: 8000304

8

Lung cancer, race, and a CYP1A1 genetic polymorphism.

Shields PG, Caporaso NE, Falk RT, Sugimura H, Trivers GE, Trump BF, Hoover RN, Weston A, Harris CC. Shields PG, et al. Cancer Epidemiol Biomarkers Prev. 1993 Sep-Oct;2(5):481-5. Cancer Epidemiol Biomarkers Prev. 1993. PMID: 8220094

9

7-Alkyldeoxyguanosine adduct detection by two-step HPLC and the 32P-postlabeling assay.

Kato S, Petruzzelli S, Bowman ED, Turteltaub KW, Blomeke B, Weston A, Shields PG. Kato S, et al. Among authors: shields pg. Carcinogenesis. 1993 Apr;14(4):545-50. doi: 10.1093/carcin/14.4.545. Carcinogenesis. 1993. PMID: 8386066

10

Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression.

Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, Klein S, Shields PG, Billiar TR, Harris CC. Ambs S, et al. Among authors: shields pg. Cancer Res. 1998 Jan 15;58(2):334-41. Cancer Res. 1998. PMID: 9443414

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

328 results

Search Page

Filters